Stereotaxis, Inc. (NASDAQ:STXS)

CAPS Rating: 3 out of 5

The Company designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite, or cath lab.

Recs

0
Player Avatar ColtHz (74.77) Submitted: 5/7/2010 1:05:56 PM : Outperform Start Price: $4.74 STXS Score: -96.70

Adding more $3.80

Featured Broker Partners


Advertisement